[Oral antidiabetic agents].
Vonesch
H J
HJ
D002096:C-Peptide / Q000502:physiology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D002096:C-Peptide; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds
Orale Antidiabetika.